Detalhe da pesquisa
1.
Adverse Events and Serological Responses After SARS-CoV-2 Vaccination in Individuals With Inflammatory Bowel Disease.
Am J Gastroenterol
; 118(9): 1693-1697, 2023 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37216598
2.
Commentary on the Epidemiology of Inflammatory Bowel Disease in Compounding Prevalence Nations: Toward Sustaining Healthcare Delivery.
Gastroenterology
; 166(6): 949-956, 2024 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-38378092
3.
Serological responses to three doses of SARS-CoV-2 vaccination in inflammatory bowel disease.
Gut
; 72(4): 802-804, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35606090
4.
Antibody response to SARS-CoV-2 among individuals with IBD diminishes over time: a serosurveillance cohort study.
Gut
; 71(6): 1229-1231, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-34340997
5.
Incidence and Prevalence of Primary Sclerosing Cholangitis: A Meta-analysis of Population-based Studies.
Inflamm Bowel Dis
; 2023 Dec 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-38052097
6.
Serological responses to the first four doses of SARS-CoV-2 vaccine in patients with inflammatory bowel disease.
Lancet Gastroenterol Hepatol
; 7(12): 1077-1079, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36306801